September 21, 2014 7:14 AM ET

Biotechnology

Company Overview of Indel Therapeutics Inc

Executive Profile

Michael J. Abrams Ph.D.

Chief Discovery Officer and Executive Vice President, Tekmira Pharmaceuticals Corporation
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 7 different industries.

See Board Relationships
58$41,250

Background

Dr. Michael J. Abrams, also known as Mike, PhD has been the Chief Discovery Officer and Executive Vice President of Tekmira Pharmaceuticals Corporation since January 6, 2014. Dr. Abrams serves as Corporate Secretary of Spartan Bioscience, Inc. He serves as Scientific Advisor of Tarix Pharmaceuticals LTD. Dr. Abrams served as the Chief Executive Officer and President at Inimex Pharmaceuticals, Inc. since November 24, 2009. He was a Co-founder of AnorMED Inc. and served ...

Corporate Headquarters

4068 West 11th Avenue
Vancouver, British Columbia V6R 2L3

Canada

Phone: 604-551-8464
Fax: 604-909-1811

Board Members Memberships

Chief Executive Officer, President and Director
Executive Chairman
1996-2006
Former Chief Executive Officer, President and Director
2001-Present
Director
2006-2008
Former Director, Member of Special Committee and Member of Compensation Committee
2008-2014
Chief Discovery Officer and Executive Vice President

Education

BA 1978
Bowdoin College
PhD 1983
Massachusetts Institute of Technology
Unknown/Other Education
University Of Ottawa

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$41,250
Total Calculated Compensation$41,250
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Mortazavi Chief Executive and Director
Silence Therapeutics plc
$70.0K
Peter French B.Sc, M.Sc, Ph.D., MBAChief Executive Officer, Managing Director and Director
Benitec Biopharma Limited
$450.0K
Hans G. C. P. Schikan Chief Executive Officer and Member of Management Board
Prosensa Holding N.V.
--
Mark W. Schwartz Ph.D.Chief Executive Officer and President
Galena Biopharma, Inc.
$490.0K
Kleanthis G. Xanthopoulos Ph.D.Chief Executive Officer, President, Principal Financial & Accounting Officer and Director
Regulus Therapeutics Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Indel Therapeutics Inc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.